Use of nitisinone in patients with alkaptonuria
Open Access
- 30 June 2005
- journal article
- Published by Elsevier BV in Metabolism
- Vol. 54 (6), 719-728
- https://doi.org/10.1016/j.metabol.2004.12.017
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pharmacokinetics and pharmacodynamics of NTBC (2‐(2‐nitro‐4‐fluoromethylbenzoyl)‐1,3‐cyclohexanedione) and mesotrione, inhibitors of 4‐hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteersBritish Journal of Clinical Pharmacology, 2001
- Maintaining a Nutrient Database in a Changing Marketplace: Keeping Pace with Changing Food Products—A Research PerspectiveJournal of Food Composition and Analysis, 2001
- Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene ( HPD ) in patients with tyrosinemia type IIIHuman Genetics, 2000
- NTBC and AlkaptonuriaAmerican Journal of Human Genetics, 1998
- The molecular basis of alkaptonuriaNature Genetics, 1996
- The Human Gene for Alkaptonuria (AKU) Maps to Chromosome 3qGenomics, 1994
- Homozygosity mapping of the gene for alkaptonuria to chromosome 3q2Nature Genetics, 1993
- Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenaseThe Lancet, 1992
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Measurement of back movement.Annals Of The Rheumatic Diseases, 1969